{
  "resourceType" : "MedicationStatement",
  "id" : "pedro-med-stat-1",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationStatement</b><a name=\"pedro-med-stat-1\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationStatement &quot;pedro-med-stat-1&quot; </p></div><p><b>status</b>: active</p><p><b>medication</b>: <a href=\"Medication-9d7be868-8264-4d94-ad04-ef04ecc92e52.html\">Medication/9d7be868-8264-4d94-ad04-ef04ecc92e52: Dovato 50 mg/300 mg (Dolutegravir/ Lamivudine) tablets</a></p><p><b>subject</b>: <a href=\"Patient-pedro-patient.html\">Patient/pedro-patient: Pedro Gravitate</a> &quot; GRAVITATE&quot;</p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td></tr><tr><td>*</td><td>Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20053000)</span></td></tr></table></div>"
  },
  "status" : "active",
  "medicationReference" : {
    "reference" : "Medication/9d7be868-8264-4d94-ad04-ef04ecc92e52",
    "display" : "Dovato 50 mg/300 mg (Dolutegravir/ Lamivudine) tablets"
  },
  "subject" : {
    "reference" : "Patient/pedro-patient",
    "display" : "Pedro Gravitate"
  },
  "dosage" : [{
    "route" : {
      "coding" : [{
        "system" : "http://standardterms.edqm.eu",
        "code" : "20053000",
        "display" : "Oral use"
      }]
    }
  }]
}